Advertisement

United-Guardian, Inc. UG

Set alert

Price alert · UG

All alert types
7.07 USD +0.41 +6.16%

At close · Oct 30

7.05 -0.02 -0.28%

After hours · Oct 30, 4:00 PM ET

Bid
6.94 × 2
Ask
7.20 × 2
6.69 Day range 7.07
5.62 52-week range 8.20
YTD
+14.77%
1 year
-3.15%
Open
6.84
Prev close
6.66
Mkt cap
32.48M
Vol
15.72K
Avg vol
9.12K
EPS
0.54
P/E
13.09
Div yield
4.89%
More statistics
Low
6.69
High
7.07
Forward P/E
0.00
Beta
0.81
Short ratio
0.54
Inst. own
23.65%
Dividend
0.60
Ex-div date
Jul 22, 2024
50-d avg
11.26
200-d avg
10.67
1y target
0.00

2Y chart

Chart tools
Interval

Events in this range
  • Nov 8, 2024Earnings: 0.19; estimate 0; surprise —%
  • Feb 10, 2025Dividend: 0.35
  • Jul 25, 2025Dividend: 0.25
  • Feb 9, 2026Dividend: 0.25
  • Jul 28, 2026Dividend: 0.3
Signals (112)
NameDateAgo
SMA: BullishOct 30, 20261 day ago
SMA: BullishOct 30, 20261 day ago
MACD: Buy SignalOct 30, 20261 day ago
SMA: BearishOct 15, 20262 weeks ago
SMA: BullishOct 14, 20262 weeks ago
SMA: BearishOct 12, 20262 weeks ago
SMA: BearishOct 7, 20263 weeks ago
SMA: BullishOct 6, 20263 weeks ago
MACD: Sell SignalOct 1, 20261 month ago
MACD: Buy SignalSep 29, 20261 month ago
MACD: Sell SignalSep 28, 20261 month ago
MACD: Buy SignalSep 10, 20261 month ago
MACD: Sell SignalSep 2, 20261 month ago
SMA: BearishAug 26, 20262 months ago
SMA: BullishAug 25, 20262 months ago
MACD: Buy SignalAug 25, 20262 months ago
SMA: BearishAug 13, 20262 months ago
SMA: BullishAug 12, 20262 months ago
SMA: BearishAug 11, 20262 months ago
SMA: BearishJul 31, 20263 months ago
SMA: BullishJul 30, 20263 months ago
SMA: BearishJul 29, 20263 months ago
MACD: Sell SignalJul 29, 20263 months ago
RSI: OverboughtJul 27, 20263 months ago
RSI: OverboughtJul 20, 20263 months ago
MACD: Buy SignalJun 23, 20264 months ago
SMA: BullishJun 11, 20264 months ago
SMA: BearishJun 10, 20264 months ago
SMA: BullishJun 9, 20264 months ago
SMA: BearishJun 8, 20264 months ago
SMA: BullishMay 11, 20265 months ago
SMA: BearishMay 6, 20265 months ago
MACD: Sell SignalMay 6, 20265 months ago
SMA: BullishApr 30, 20266 months ago
SMA: BearishApr 27, 20266 months ago
SMA: BullishApr 24, 20266 months ago
SMA: BullishApr 15, 20266 months ago
SMA: BearishApr 8, 20266 months ago
SMA: BullishApr 7, 20266 months ago
SMA: BearishApr 2, 20267 months ago
SMA: BullishMar 30, 20267 months ago
MACD: Buy SignalMar 30, 20267 months ago
MACD: Sell SignalMar 18, 20267 months ago
SMA: BearishMar 16, 20267 months ago
SMA: BullishMar 13, 20267 months ago
MACD: Buy SignalMar 13, 20267 months ago
SMA: BearishMar 12, 20267 months ago
SMA: BullishMar 11, 20267 months ago
SMA: BearishMar 4, 20268 months ago
SMA: BullishMar 3, 20268 months ago
SMA: BearishMar 2, 20268 months ago
MACD: Sell SignalFeb 10, 20268 months ago
SMA: BearishFeb 3, 20269 months ago
SMA: BullishFeb 2, 20269 months ago
RSI: OverboughtJan 29, 20269 months ago
RSI: OverboughtJan 16, 20269 months ago
SMA: BullishJan 7, 20269 months ago
RSI: OversoldDec 2, 202511 months ago
MACD: Buy SignalDec 1, 202511 months ago
RSI: OversoldNov 6, 202511 months ago
MACD: Sell SignalOct 30, 20251 year ago
MACD: Buy SignalOct 29, 20251 year ago
MACD: Sell SignalOct 27, 20251 year ago
MACD: Buy SignalOct 17, 20251 year ago
MACD: Sell SignalOct 3, 20251 year ago
MACD: Buy SignalOct 2, 20251 year ago
MACD: Sell SignalSep 12, 20251 year ago
SMA: BearishSep 11, 20251 year ago
SMA: BullishAug 29, 20251 year ago
SMA: BearishAug 25, 20251 year ago
SMA: BullishAug 21, 20251 year ago
MACD: Buy SignalAug 21, 20251 year ago
SMA: BearishJul 29, 20251 year ago
SMA: BullishJul 28, 20251 year ago
MACD: Sell SignalJul 28, 20251 year ago
SMA: BearishJul 25, 20251 year ago
RSI: OverboughtJul 21, 20251 year ago
SMA: BullishJul 15, 20251 year ago
RSI: OverboughtJul 15, 20251 year ago
MACD: Buy SignalJul 10, 20251 year ago
SMA: BearishJul 8, 20251 year ago
MACD: Sell SignalJul 8, 20251 year ago
SMA: BullishJul 7, 20251 year ago
MACD: Buy SignalJul 7, 20251 year ago
MACD: Sell SignalJun 30, 20251 year ago
SMA: BearishJun 27, 20251 year ago
SMA: BullishJun 25, 20251 year ago
MACD: Buy SignalJun 25, 20251 year ago
SMA: BearishJun 17, 20251 year ago
MACD: Sell SignalJun 17, 20251 year ago
SMA: BullishJun 16, 20251 year ago
MACD: Buy SignalJun 16, 20251 year ago
MACD: Sell SignalJun 13, 20251 year ago
SMA: BearishJun 12, 20251 year ago
SMA: BullishJun 11, 20251 year ago
MACD: Buy SignalJun 11, 20251 year ago
SMA: BearishJun 10, 20251 year ago
MACD: Sell SignalJun 10, 20251 year ago
SMA: BullishJun 9, 20251 year ago
SMA: BearishMay 21, 20251 year ago
SMA: BullishMay 20, 20251 year ago
MACD: Buy SignalApr 21, 20251 year ago
RSI: OversoldApr 14, 20251 year ago
RSI: OversoldApr 7, 20251 year ago
MACD: Sell SignalMar 24, 20251 year ago
MACD: Buy SignalMar 19, 20251 year ago
SMA: BearishFeb 24, 20251 year ago
MACD: Sell SignalFeb 10, 20251 year ago
RSI: OverboughtJan 30, 20251 year ago
RSI: OversoldDec 23, 20241 year ago
RSI: OversoldDec 18, 20241 year ago
RSI: OversoldDec 10, 20241 year ago

Key statistics

Market cap
43.83M
Enterprise value
46.51M
Trailing P/E
12.55
Forward P/E
0.00
PEG ratio
0.00
Price / sales
3.56
Price / book
3.85
EPS (TTM)
0.76
Beta
0.81
Dividend yield
4.89%
Payout ratio
49.30%
Profit margin
26.37%
Revenue (TTM)
12.31M
Revenue growth
27.90%
Free cash flow
3.16M
Total cash
9.86M
Total debt
0
Return on equity
28.72%
Shares outstanding
4.59M
Short % of float
0.39%
50-day average
11.26
200-day average
10.67

Analyst view

Consensus: none

Price target (mean) 0.00

Next earnings

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
UG Revenue — quarterly 3.11M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
UG Net income — quarterly 728.58K
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
UG EPS — quarterly 0.16
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

UG recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 8, 2024Sep 1, 20240.000.19——
Aug 9, 2024Jun 1, 20240.000.21——
May 10, 2024Mar 1, 20240.000.20——
Mar 22, 2024Dec 1, 20230.000.16——
Nov 6, 2023Sep 1, 20230.000.14——
Aug 11, 2023Jun 1, 20230.000.10——

About United-Guardian, Inc.

United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL MGL, a medical lubricant with a lower viscosity medical lubricant; LUBRAJEL LC, LUBRAJEL BA, and LUBRAJEL FA, which are formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial used in urology. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and product development of cosmetic ingredients. United-Guardian, Inc. was founded in 1942 and is based in Hauppauge, New York.

Sector
Consumer Defensive
Industry
Household & Personal Products
Country
United States
Website
u-g.com

News

Your note

Sign in to keep a note on UG — it syncs with the Stock Master app.

Institution ownership

UG institution ownership
Holder% heldSharesValueReported
Renaissance Technologies, LLC3.97%182,3631.74MSep 29, 2024
Gamco Investors Inc3.45%158,5001.51MSep 29, 2024
Vanguard Group Inc2.99%137,3561.31MSep 29, 2024
Rodgers Brothers Inc.2.13%97,877933.75KSep 29, 2024
Dimensional Fund Advisors LP1.68%77,230736.77KSep 29, 2024
Teton Advisors, Inc1.19%54,761522.42KSep 29, 2024

Fund ownership

UG fund ownership
Holder% heldSharesValueReported
EQ Advisors Trust-1290 VT Gamco Small Company Value Port3.29%151,0001.44MSep 29, 2024
Vanguard Total Stock Market Index Fund1.72%79,196755.53KSep 29, 2024
Teton Westwood Mighty Mites Fd1.19%54,761522.42KSep 29, 2024
Vanguard Extended Market Index Fund1.14%52,417500.06KSep 29, 2024
Gabelli Small Cap Growth Fund0.83%38,000362.52KSep 29, 2024
DFA U.S. Micro Cap Series0.73%33,435318.97KJul 30, 2024
Advertisement